Abstract

This study was designed to determine the role of altered cyclooxygenase metabolism in impaired pial artery dilation to the newly described opioid, nociceptin orphanin FQ (NOC/oFQ), following fluid percussion brain injury (FPI) in newborn pigs equipped with a closed cranial window. Recent studies show that NOC/oFQ contributes to oxygen free radical generation observed post FPI in a cyclooxygenase dependent manner. FPI was produced by using a pendulum to strike a piston on a saline filled cylinder that was fluid coupled to the brain via a hollow screw inserted through the cranium. NOC/oFQ (10 −8, 10 −6 M) modestly increased cerebrospinal fluid (CSF) 6-keto-PGF 1α, and thromboxane B 2 (TXB 2), the stable breakdown products of PGI 2 and TXA 2, in sham animals (1148 ± 83 to 1681 ± 114 and 308 ± 16 to 424 ± 21 pg/ml for control and 10 −6 M NOC/oFQ 6-keto-PGF 1α, and TXB 2, respectively). In 1-h post FPI animals, basal levels of 6-keto-PGF 1α, and TXB 2 were elevated. NOC/oFQ stimulated release of 6-keto-PGF 1α, was blocked while such release of TXB 2 was enhanced (720 ± 63 to 1446 ± 117 pg/ml for control and 10 −6 M NOC/oFQ CSF TXB 2). NOC/oFQ (10 −8, 10 −6 M) induced pial artery dilation that was reversed to vasoconstriction by FPI while the cyclooxygenase inhibitor indomethacin (5 mg/kg, intravenous) partially restored such vascular responses (8 ± 1 and 15 ± 1 vs. −7 ± 1 and −12 ± 1 vs. 7 ± 1 and 12 ± 1% for 10 −8, 10 −6 M NOC/oFQ in sham, FPI and FPI-Indo pretreated animals). Similar observations were made in FPI animals pretreated with the thromboxane receptor antagonist SQ 29,548 or the free radical scavenger polyethylene glycol superoxide dismutase and catalase. These data indicate that altered NOC/oFQ induced cyclooxygenase metabolism contributes to impairment of dilation to this opioid following FPI.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.